Loading...
XNASRDNT
Market cap5.35bUSD
Jan 08, Last price  
72.25USD
1D
-0.25%
1Q
11.17%
Jan 2017
1,020.16%
Name

RadNet Inc

Chart & Performance

D1W1MN
XNAS:RDNT chart
P/E
1,757.04
P/S
3.31
EPS
0.04
Div Yield, %
0.00%
Shrs. gr., 5y
5.84%
Rev. gr., 5y
10.64%
Revenues
1.62b
+13.05%
137,277,000145,573,000161,005,000425,470,000502,118,000524,368,000548,537,000619,800,000647,153,000702,986,000717,569,000809,628,000884,535,000922,186,000975,146,0001,154,179,0001,071,840,0001,315,077,0001,430,061,0001,616,630,000
Net income
3m
-90.94%
-14,576,000-3,135,000-6,894,000-18,131,000-12,836,000-2,267,000-12,852,0007,231,00064,517,0002,120,0001,376,0007,709,0007,230,00053,00032,243,00023,440,000-1,749,00044,319,00033,608,0003,044,000
CFO
221m
+50.85%
17,054,00022,002,00010,251,00029,201,00045,201,00076,618,00066,884,00057,636,00074,033,00066,422,00061,004,00067,037,00091,599,000141,187,000116,754,000104,322,000233,759,000149,491,000146,417,000220,863,000
Earnings
Feb 26, 2025

Profile

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
URL
https://www.radnet.com/
IPO date
Dec 12, 2001
Employees
9,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,616,630
13.05%
1,430,061
8.74%
Cost of revenue
1,395,239
1,264,346
Unusual Expense (Income)
NOPBT
221,391
165,715
NOPBT Margin
13.69%
11.59%
Operating Taxes
8,473
9,361
Tax Rate
3.83%
5.65%
NOPAT
212,918
156,354
Net income
3,044
-90.94%
33,608
-24.17%
Dividends
Dividend yield
Proceeds from repurchase of equity
245,832
294
BB yield
-10.93%
-0.03%
Debt
Debt current
129,936
70,007
Long-term debt
2,078,243
2,105,185
Deferred revenue
Other long-term liabilities
6,721
23,015
Net debt
1,772,899
1,989,465
Cash flow
Cash from operating activities
220,863
146,417
CAPEX
(176,600)
(249,412)
Cash from investing activities
(201,470)
(246,949)
Cash from financing activities
195,635
93,647
FCF
152,438
84,939
Balance
Cash
342,570
127,834
Long term investments
92,710
57,893
Excess cash
354,448
114,224
Stockholders' equity
90,609
55,164
Invested Capital
2,276,572
1,972,771
ROIC
10.02%
8.85%
ROCE
9.29%
8.13%
EV
Common stock shares outstanding
64,658
57,321
Price
34.77
84.65%
18.83
-37.46%
Market cap
2,248,169
108.29%
1,079,352
-32.90%
EV
4,203,732
3,227,274
EBITDA
410,884
350,439
EV/EBITDA
10.23
9.21
Interest
64,483
50,841
Interest/NOPBT
29.13%
30.68%